Private Wealth Management Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Private Wealth Management Group’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.39K	Hold	218	–	–	﹤0.01%	938
2026 Q2	$5.52K	Hold	218	–	–	﹤0.01%	815
2026 Q1	$4.85K	Hold	218	–	–	﹤0.01%	784
2025 Q4	$5.82K	Hold	218	–	–	﹤0.01%	715
2025 Q3	$4.65K	Hold	218	–	–	﹤0.01%	817
2025 Q2	$4.7K	Sell	218 -72	-25%	-$1.34K	﹤0.01%	777
2025 Q1	$4.82K	Hold	290	–	–	﹤0.01%	741
2024 Q4	$5.32K	Buy	+290	New	+$4.68K	﹤0.01%	717
2024 Q3	–	Sell	-63	Closed	-$1.02K	–	1500
2024 Q2	$1.02K	Buy	63 +20	+47%	+$323	﹤0.01%	1283
2024 Q1	$796	Hold	43	–	–	﹤0.01%	1339
2023 Q4	$1.35K	Buy	+43	New	+$1.03K	﹤0.01%	1155

Other funds holding ACAD

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Private Wealth Management Group's ACAD Position: Q3 2026 in Review

Private Wealth Management Group held its Acadia Pharmaceuticals (ACAD) position steady in Q3 2026 at 218 shares worth $4.39K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Private Wealth Management Group first reported a position in ACAD in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.82K in Q4 2025. 49 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

Private Wealth Management Group held 218 shares of Acadia Pharmaceuticals worth $4.39K as of Q3 2026.
Private Wealth Management Group left its Acadia Pharmaceuticals share count unchanged in Q3 2026.
Acadia Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q3 2026, its #938 holding.
Private Wealth Management Group first reported a position in Acadia Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Private Wealth Management Group's Acadia Pharmaceuticals position peaked at $5.82K in Q4 2025.
49 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Private Wealth Management Group's 13F filing for Q3 2026, filed 19 Oct 2026.